Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00032260.xml
Download PDF
Digestive Disease Interventions 2019; 03(03): 203-213
DOI: 10.1055/s-0039-1693414
DOI: 10.1055/s-0039-1693414
Review Article
Pediatric Lymphangiography: Imaging to Intervention
Further Information
Publication History
06 March 2019
15 May 2019
Publication Date:
22 August 2019 (online)
Abstract
The lymphatic system plays a crucial role in fluid transport as well as facilitating immune recognition. Disruption of lymphatic flow can lead to significant morbidity and mortality in the pediatric population, manifesting as lymphatic malformations and lymphatic leaks. There has been rising interest in developing minimally invasive image-guided approaches to diagnose and treat lymphatic disorders in pediatric patients. Notably, magnetic resonance imaging of the lymphatic system has emerged as a promising diagnostic tool. Moreover, interventions such as sclerotherapy and thoracic duct embolization for treatment of lymphatic malformations and leaks have come forth as safe and effective alternatives to surgery. The aim of this article is to review various pediatric lymphatic disorders and discuss advances in image-guided diagnostic and therapeutic options for these entities.
Disclosure
The authors have no relevant disclosures.
All authors have read and contributed to this manuscript.
-
References
- 1 Cope C, Salem R, Kaiser LR. Management of chylothorax by percutaneous catheterization and embolization of the thoracic duct: prospective trial. J Vasc Interv Radiol 1999; 10 (09) 1248-1254
- 2 Cope C, Kaiser LR. Management of unremitting chylothorax by percutaneous embolization and blockage of retroperitoneal lymphatic vessels in 42 patients. J Vasc Interv Radiol 2002; 13 (11) 1139-1148
- 3 Nadolski GJ, Itkin M. Feasibility of ultrasound-guided intranodal lymphangiogram for thoracic duct embolization. J Vasc Interv Radiol 2012; 23 (05) 613-616
- 4 Rajebi MR, Chaudry G, Padua HM. , et al. Intranodal lymphangiography: feasibility and preliminary experience in children. J Vasc Interv Radiol 2011; 22 (09) 1300-1305
- 5 Johnson OW, Chick JFB, Chauhan NR. , et al. The thoracic duct: clinical importance, anatomic variation, imaging, and embolization. Eur Radiol 2016; 26 (08) 2482-2493
- 6 Chavhan GB, Amaral JG, Temple M, Itkin M. MR lymphangiography in children: technique and potential applications. Radiographics 2017; 37 (06) 1775-1790
- 7 Bhardwaj R, Vaziri H, Karimeddini D, Gautam A, Ballesteros E, Wu GY. Chylous ascites: a review of pathogenesis, diagnosis and treatment. J Clin Transl J Clin Transl Hepatol 2018; 6 (01) 105-113
- 8 Temple M, Krishnamurthy G. Vascular interventions: lymphangiography and thoracic duct embolizations. In: Temple M, Marshalleck FE. , eds. pediatric interventional radiology: handbook of vascular and non-vascular interventions. New York, NY: Springer; 2014: 251-261
- 9 Chen E, Itkin M. Thoracic duct embolization for chylous leaks. Semin Intervent Radiol 2011; 28 (01) 63-74
- 10 Feldt RH, Driscoll DJ, Offord KP. , et al. Protein-losing enteropathy after the Fontan operation. J Thorac Cardiovasc Surg 1996; 112 (03) 672-680
- 11 Kennedy TL, Whitaker M, Pellitteri P, Wood WE. Cystic hygroma/lymphangioma: a rational approach to management. Laryngoscope 2001; 111 (11 Pt 1): 1929-1937
- 12 Dubois J, Garel L, Abela A, Laberge L, Yazbeck S. Lymphangiomas in children: percutaneous sclerotherapy with an alcoholic solution of zein. Radiology 1997; 204 (03) 651-654
- 13 Defnet AM, Bagrodia N, Hernandez SL, Gwilliam N, Kandel JJ. Pediatric lymphatic malformations: evolving understanding and therapeutic options. Pediatr Surg Int 2016; 32 (05) 425-433
- 14 Alqahtani A, Nguyen LT, Flageole H, Shaw K, Laberge JM. 25 years' experience with lymphangiomas in children. J Pediatr Surg 1999; 34 (07) 1164-1168
- 15 Schoinohoriti OK, Theologie-Lygidakis N, Tzerbos F, Iatrou I. Lymphatic malformations in children and adolescents. J Craniofac Surg 2012; 23 (06) 1744-1747
- 16 Francavilla ML, White CL, Lee EY, Oliveri B, Restrepo R. Intraabdominal Lymphatic Malformations: Pearls and Pitfalls of Diagnosis and Differential Diagnoses in Pediatric Patients. AJR Am J Roentgenol 2017; 208 (3): 637-649
- 17 Brouillard P, Boon L, Vikkula M. Genetics of lymphatic anomalies. J Clin Invest 2014; 124 (03) 898-904
- 18 Connell FC, Ostergaard P, Carver C. , et al; Lymphoedema Consortium. Analysis of the coding regions of VEGFR3 and VEGFC in Milroy disease and other primary lymphoedemas. Hum Genet 2009; 124 (06) 625-631
- 19 Mäkinen T, Veikkola T, Mustjoki S. , et al. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J 2001; 20 (17) 4762-4773
- 20 Acord M, Srinivasan AS, Cahill AM. Percutaneous treatment of lymphatic malformations. Tech Vasc Interv Radiol 2016; 19 (04) 305-311
- 21 Strychowsky JE, Rahbar R, O'Hare MJ, Irace AL, Padua H, Trenor III CC. Sirolimus as treatment for 19 patients with refractory cervicofacial lymphatic malformation. Laryngoscope 2018; 128 (01) 269-276
- 22 García-Montero P, Del Boz J, Sanchez-Martínez M, Escudero Santos IM, Baselga E. Microcystic lymphatic malformation successfully treated with topical rapamycin. Pediatrics 2017; 139 (05) e20162105 . Doi: 10.1542/peds.2016-2105
- 23 Ivars M, Redondo P. Efficacy of topical sirolimus (Rapamycin) for the treatment of microcystic lymphatic malformations. JAMA Dermatol 2017; 153 (01) 103-105
- 24 Okazaki T, Iwatani S, Yanai T. , et al. Treatment of lymphangioma in children: our experience of 128 cases. J Pediatr Surg 2007; 42 (02) 386-389
- 25 Balakrishnan K, Menezes MD, Chen BS, Magit AE, Perkins JA. Primary surgery vs primary sclerotherapy for head and neck lymphatic malformations. JAMA Otolaryngol Head Neck Surg 2014; 140 (01) 41-45
- 26 Shergill A, John P, Amaral JG. Doxycycline sclerotherapy in children with lymphatic malformations: outcomes, complications and clinical efficacy. Pediatr Radiol 2012; 42 (09) 1080-1088
- 27 Alomari AI, Karian VE, Lord DJ, Padua HM, Burrows PE. Percutaneous sclerotherapy for lymphatic malformations: a retrospective analysis of patient-evaluated improvement. J Vasc Interv Radiol 2006; 17 (10) 1639-1648
- 28 Thottam PJ, Al-Barazi R, Madgy DN, Rozzelle A. Submucosal resection of a microcystic oropharyngeal lymphatic malformation using radiofrequency ablation. Int J Pediatr Otorhinolaryngol 2013; 77 (09) 1589-1592
- 29 Colbert SD, Seager L, Haider F, Evans BT, Anand R, Brennan PA. Lymphatic malformations of the head and neck-current concepts in management. Br J Oral Maxillofac Surg 2013; 51 (02) 98-102
- 30 Shaikh R. Percutaneous image-guided cryoablation in vascular anomalies. Semin Intervent Radiol 2017; 34 (03) 280-287
- 31 Tutor JD. Chylothorax in infants and children. Pediatrics 2014; 133 (04) 722-733
- 32 Chan EH, Russell JL, Williams WG, Van Arsdell GS, Coles JG, McCrindle BW. Postoperative chylothorax after cardiothoracic surgery in children. Ann Thorac Surg 2005; 80 (05) 1864-1870
- 33 Chan S yan, Lau W, Wong WHS, Cheng L cheung, Chau AKT, Cheung Y fai. Chylothorax in Children After Congenital Heart Surgery. Ann Thorac Surg 2006; 82 (05) 1650-1656
- 34 Campagna J, Jain R. Thoracic duct embolization. In: Kessel D, Ray C. eds. Transcatheter embolization and therapy. London: Springer; 2010: 471-472
- 35 Maldonado F, Cartin-Ceba R, Hawkins FJ, Ryu JH. Medical and surgical management of chylothorax and associated outcomes. Am J Med Sci 2010; 339 (04) 314-318
- 36 Krishnamurthy R, Hernandez A, Kavuk S, Annam A, Pimpalwar S. Dynamic magnetic resonance lymphangiography (MRL): A new technique to image the central conducting lymphatics (CCL). J Vasc Interv Radiol 2013; 24 (04) S28
- 37 Pamarthi V, Pabon-Ramos WM, Marnell V, Hurwitz LM. MRI of the central lymphatic system: indications, imaging technique, and pre-procedural planning. Top Magn Reson Imaging 2017; 26 (04) 175-180
- 38 Nadolski GJ, Ponce-Dorrego MD, Darge K, Biko DM, Itkin M. Validation of the position of injection needles with contrast-enhanced ultrasound for dynamic contract-enhanced MR lymphangiography. J Vasc Interv Radiol 2018; 29 (07) 1028-1030
- 39 Kawasaki R, Sugimoto K, Fujii M. , et al. Therapeutic effectiveness of diagnostic lymphangiography for refractory postoperative chylothorax and chylous ascites: correlation with radiologic findings and preceding medical treatment. AJR Am J Roentgenol 2013; 201 (03) 659-666
- 40 Matsumoto T, Yamagami T, Kato T. , et al. The effectiveness of lymphangiography as a treatment method for various chyle leakages. Br J Radiol 2009; 82 (976) 286-290
- 41 Yamagami T, Masunami T, Kato T. , et al. Spontaneous healing of chyle leakage after lymphangiography. Br J Radiol 2005; 78 (933) 854-857
- 42 Gray M, Kovatis KZ, Stuart T. , et al. Treatment of congenital pulmonary lymphangiectasia using ethiodized oil lymphangiography. J Perinatol 2014; 34 (09) 720-722
- 43 Gough MH. Lymphangiography in children. Arch Dis Child 1964; 39: 177-181
- 44 Itkin M, Krishnamurthy G, Naim MY, Bird GL, Keller MS. Percutaneous thoracic duct embolization as a treatment for intrathoracic chyle leaks in infants. Pediatrics 2011; 128 (01) e237-e241
- 45 Nair SK, Petko M, Hayward MP. Aetiology and management of chylothorax in adults. Eur J Cardiothorac Surg 2007; 32 (02) 362-369
- 46 Berzigotti A, Magalotti D, Cocci C, Angeloni L, Pironi L, Zoli M. Octreotide in the outpatient therapy of cirrhotic chylous ascites: a case report. Dig Liver Dis 2006; 38 (02) 138-142
- 47 Ferguson MK, Little AG, Skinner DB. Current concepts in the management of postoperative chylothorax. Ann Thorac Surg 1985; 40 (06) 542-545
- 48 Nath DS, Savla J, Khemani RG, Nussbaum DP, Greene CL, Wells WJ. Thoracic duct ligation for persistent chylothorax after pediatric cardiothoracic surgery. Ann Thorac Surg 2009; 88 (01) 246-251
- 49 Cope C. Management of chylothorax via percutaneous embolization. Curr Opin Pulm Med 2004; 10 (04) 311-314
- 50 McGrath EE, Blades Z, Anderson PB. Chylothorax: aetiology, diagnosis and therapeutic options. Respir Med 2010; 104 (01) 1-8
- 51 Binkert CA, Yucel EK, Davison BD, Sugarbaker DJ, Baum RA. Percutaneous treatment of high-output chylothorax with embolization or needle disruption technique. J Vasc Interv Radiol 2005; 16 (09) 1257-1262
- 52 Litherland B, Given M, Lyon S. Percutaneous radiological management of high-output chylothorax with CT-guided needle disruption. J Med Imaging Radiat Oncol 2008; 52 (02) 164-167
- 53 Pamarthi V, Stecker MS, Schenker MP. , et al. Thoracic duct embolization and disruption for treatment of chylous effusions: experience with 105 patients. J Vasc Interv Radiol 2014; 25 (09) 1398-1404
- 54 Itkin M, Kucharczuk JC, Kwak A, Trerotola SO, Kaiser LR. Nonoperative thoracic duct embolization for traumatic thoracic duct leak: experience in 109 patients. J Thorac Cardiovasc Surg 2010; 139 (03) 584-589
- 55 Majdalany BS, Saad WA, Chick JFB, Khaja MS, Cooper KJ, Srinivasa RN. Pediatric lymphangiography, thoracic duct embolization and thoracic duct disruption: a single-institution experience in 11 children with chylothorax. Pediatr Radiol 2018; 48 (02) 235-240
- 56 Chung A, Gill AE, Rahman FN, Hawkins CM. Retrograde thoracic duct embolization in a pediatric patient with total cavopulmonary connection and plastic bronchitis. J Vasc Interv Radiol 2015; 26 (11) 1743-1746
- 57 Kim J, Won JH. Percutaneous treatment of chylous ascites. Tech Vasc Interv Radiol 2016; 19 (04) 291-298
- 58 Lee EW, Shin JH, Ko HK, Park J, Kim SH, Sung KB. Lymphangiography to treat postoperative lymphatic leakage: a technical review. Korean J Radiol 2014; 15 (06) 724-732
- 59 Itkin M, Piccoli DA, Nadolski G. , et al. Protein-Losing Enteropathy in Patients With Congenital Heart Disease. J Am Coll Cardiol 2017; 69 (24) 2929-2937
- 60 Mertens L, Hagler DJ, Sauer U, Somerville J, Gewillig M. Protein-losing enteropathy after the Fontan operation: an international multicenter study. PLE study group. J Thorac Cardiovasc Surg 1998; 115 (05) 1063-1073
- 61 Copland A, DiBaise J. Protein losing enteropathy: diagnosis and management. Pract Gastroenterol 2017; 162: 22-35
- 62 Levitt DG, Levitt MD. Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements. Int J Gen Med 2016; 9: 229-255
- 63 Udink Ten Cate FE, Hannes T, Germund I. , et al. Towards a proposal for a universal diagnostic definition of protein-losing enteropathy in Fontan patients: a systematic review. Heart 2016; 102 (14) 1115-1119
- 64 Umar SB, DiBaise JK. Protein-losing enteropathy: case illustrations and clinical review. Am J Gastroenterol 2010; 105 (01) 43-49 , quiz 50